DETERMINATION OF L-ALANOSINE IN PLASMA AND URINE BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY OF THE DNS DERIVATIVEPOWIS G; AMES MM.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 170; NO 1; PP. 195-201; BIBL. 18 REF.Article

DETERMINATION OF 6-DIAZO-5-OXO-L-NORLEUCINE IN PLASMA AND URINE BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY OF THE DANSYL DERIVATIVEPOWIS G; AMES MM.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 181; NO 1; PP. 95-99; BIBL. 14 REF.Article

DETERMINATION OF PENTAMETHYLMELAMINE AND HEXAMETHYLMELAMINE IN PLASMA AND URINE BY NITROGEN-PHOSPHORUS GAS-LIQUID CHROMATOGRAPHYAMES MM; POWIS G.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 174; NO 1; PP. 245-249; BIBL. 14 REF.Article

DETERMINATION OF INDICINE N-OXIDE AND INDICINE IN PLASMA AND URINE BY ELECTRON-CAPTURE GAS-LIQUID CHROMATOGRAPHYAMES MM; POWIS G.1978; J. CHROMATOGR.; NLD; DA. 1978; VOL. 166; NO 2; PP. 519-526; BIBL. 19 REF.Article

GAS-CHROMATOGRAPHIC RESOLUTION OF THE ENANTIOMERS OF 3-(3,4-DIHYDROXYPHENYL) ALANINE AND ITS ALPHA -METHYL ANALOG.GAL J; AMES MM.1977; ANAL. BIOCHEM.; U.S.A.; DA. 1977; VOL. 83; NO 1; PP. 266-273; BIBL. 20 REF.Article

PARENTERAL FORMULATION OF HEXAMETHYLMELAMINE POTENTIALLY SUITABLE FOR USE IN MANAMES MM; KOVACH JS.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 7; PP. 1579-1581; BIBL. 20 REF.Article

STEREOCHEMICAL ASPECTS OF PARA-CHLOROAMPHETAMINE METABOLISM. RABBIT LIVER MICROSOMAL METABOLISM OF RS-, R(-)-, AND S(+)-PARA-CHLOROAMPHETAMINEAMES MM; FRANK SK.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 1; PP. 5-9; BIBL. 28 REF.Article

DOSE-DEPENDENT PHARMACOKINETICS AND CANCER CHEMOTHERAPYPOWIS G; AMES MM; KOVACH JS et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 1; PP. 1-9; BIBL. 117 REF.Article

THE EFFECT OF ETHYLENE GLYCOL BIS-(BETA -AMINOETHYL ETHER)-N,N'-TETRAACETIC ACID AND CALCIUM ON TYROSINE HYDROXYLASE ACTIVITY.LERNER P; AMES MM; LOVENBERG N et al.1977; MOLEC. PHARMACOL.; U.S.A.; DA. 1977; VOL. 13; NO 1; PP. 44-49; BIBL. 12 REF.Article

ROLE OF N-METHYLOLPENTAMETHYLMELAMINE IN THE METABOLIC ACTIVATION OF HEXAMETHYLMELAMINE = ROLE DE LA N-METHYLOLPENTAMETHYLMELAMINE DANS L'ACTIVATION METABOLIQUE DE L'HEXAMETHYLMELAMINEAMES MM; SANDERS ME; TIEDE WS et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 2; PP. 500-504; ABS. ENG; BIBL. 34 REF.; GRAPH, FIGArticle

METABOLIC CONVERSION OF INDICINE N-OXIDE TO INDICINE IN RABBITS AND HUMANSPOWIS G; AMES MM; KOVACH JS et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 9; PP. 3564-3570; BIBL. 43 REF.Article

SELECTION OF A REFERENCE PARTITIONING SYSTEM FOR DRUG DESIGN WORK = SELECTION D'UN SYSTEME DE REPARTITION DE REFERENCE POUR LE TRAVAIL SUR LA CONCEPTION DE MEDICAMENTSSMITH RN; HANSCH C; AMES MM et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 4; PP. 599-606; BIBL. 63REF.Article

DETERMINATION PYRAZOLOIMIDAZOLE IN PLASMA AND EVIME BY GAS-LIQUID CHROMATOGRAPHY USING NITROGEN-PHOSPHORUS DETECTIONAMES MM; POWIS G; KUEHN P et al.1979; J. CHROMATOGR.; NLD; DA. 1979-02; VOL. 169; PP. 412-415; BIBL. 4 REF.Article

TYROSINE HYDROXYLASE. ACTIVATION BY PROTEIN PHOSPHORYLATION AND END PRODUCT INHIBITION.AMES MM; LERNER P; LOVENBERG W et al.1978; J. BIOL. CHEM.; U.S.A.; DA. 1978; VOL. 253; NO 1; PP. 27-31; BIBL. 20 REF.Article

METABOLIC ACTIVATION OF HEXAMETHYLMELAMINE AND PENTAMETHYLMELAMINE BY LIVER MICROSOMAL PREPARATIONSAMES MM; SANDERS ME; TIEDE WS et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 15; PP. 1591-1598; BIBL. 23 REF.Article

A SIMPLE METHOD FOR THE ESTIMATION OF AMYGDALIN IN URINE.FLORA KP; CRADOCK JC; AMES MM et al.1978; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1978; VOL. 20; NO 2; PP. 367-378; BIBL. 15 REF.Article

STEREOCHEMICAL COURSE IN VIVO OF ALPHA-METHYLDOPA DECARBOXYLATION IN RAT BRAINS.AMES MM; MELMON KL; CASTAGNOLI N JR et al.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 19; PP. 1757-1762; BIBL. 26 REF.Article

RELATIONSHIP OF THE REDUCTIVE METABOLISM OF INDICINE-N-OXIDE TO ITS ANTITUMOR ACTIVITYPOWIS G; AMES MM; KOVACH JS et al.1979; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1979; VOL. 24; NO 3; PP. 559-569; BIBL. 2 P.Article

INITIAL PHARMACOLOGIC STUDIES OF AMYGDALIN (LACTRILE) IN MANAMES MM; KOVACH JS; FLORA KP et al.1978; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1978; VOL. 22; NO 1; PP. 175-185; BIBL. 21 REF.Article

CYTOCHROME P-450 AND NAPPH CYTOCHROME C REDUCTASE IN RAT BRAIN: FORMATION OF CATECHOLS AND REACTIVE CATECHOL METABOLITES.SASAME HA; AMES MM; NELSON SD et al.1977; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1977; VOL. 78; NO 3; PP. 919-926; BIBL. 17 REF.Article

CLINICAL AND PHARMACOLOGIC EVALUATION OF SPLIT-DOSE INTERMITTENT THERAPY WITH DIANHYDROGALACTITOLEAGAN RT; AMES MM; POWIS G et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 283-287; BIBL. 12 REF.Article

ANTICANCER DRUG TESTING IN VITRO: USE OF AN ACTIVATING SYSTEM WITH THE HUMAN TUMOR STEM CELL ASSAYLIEBER MM; AMES MM; POWIS G et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 3; PP. 287-293; BIBL. 28 REF.Article

PHASE 1 TRIAL AND ASSAY OF RUBIDAZONE (NSC 164011) IN PATIENTS WITH ADVANCED SOLID TUMORSKOVACH JS; AMES MM; STERNAD ML et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 3; PP. 823-828; BIBL. 15 REF.Article

DISPOSITION AND METABOLISM OF PENTAMETHYLMELAMINE AND HEXAMETHYLMELAMINE IN RABBITS AND HUMANSAMES MM; POWIS G; KOVACH JS et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 12; PP. 5016-5021; BIBL. 15 REF.Article

PHARMACOLOGY OF AMYGDALIN (LAETRILE) IN CANCER PATIENTSAMES MM; MOYER TP; KOVACH JS et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 1; PP. 51-57; BIBL. 26 REF.Article